Latest Share Chat

Hikma Prices USD500 Million Five-Year Eurobond (ALLISS)

Wed, 01st Apr 2015 16:43

LONDON (Alliance News) - Hikma Pharmaceuticals PLC Wednesday said it has priced a USD500 million 4.25% eurobond due April 2020, with the proceeds to be used to refinance existing debt and for "general" corporate purposes.

The bond will be listed on the Global Exchange Market of the Irish Stock Exchange.

The joint lead managers were Citi, Barclays, HSBC and National Bank of Abu Dhabi.

Hikma shares closed up 0.1% at 2,131.00 pence in London on Wednesday.

By Samuel Agini; samagini@alliancenews.com; @samuelagini

Related Shares

More News

3 May 2024 09:14

LONDON BROKER RATINGS: Jefferies cuts AJ Bell; Deutsche likes ConvaTec

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

26 Apr 2024 13:36

UK dividends calendar - next 7 days

25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth readi...

25 Apr 2024 10:15

Hikma Pharmaceuticals backs outlook after making strong start to 2024

(Alliance News) - Hikma Pharmaceuticals PLC on Thursday reported an encouraging start to the year supported by all three business segments.

25 Apr 2024 08:01

Hikma delivers strong Q1, holds on to guidance

(Sharecast News) - Pharmaceuticals group Hikma said it has made a "strong and encouraging start" to 2024, with all three business segments performing ...